Weina Ma

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Chronic Myeloid Leukemia

Top Venues

Journal of molecular recognition : JMR

Journal of cellular and molecular medicine

Current cancer drug targets

Journal of biochemical and molecular toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Jinna Liang, Panpan Lei, Xinyue Su, Jiapan Gao, Bingxi Ren, Yuxiu Zhang, Xiaoyu Ma, Weina Ma
Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner. Current cancer drug targets (2024)
Weina Ma, Man Zhu, Bo Wang, Zhengyan Gong, Xia Du, Tianfeng Yang, Xianpeng Shi, Bingling Dai, Yingzhuan Zhan, Dongdong Zhang, Yanhong Ji, Yang Wang, Song Li, Yanmin Zhang
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type-B receptor 4. Molecular oncology 16 (14) (2022)
Jue Wang, Yongjing Zhang, Shiling Hu, Haoyun Bai, Zhuoyin Xue, Yanhong Liu, Weina Ma
Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein. Journal of biochemical and molecular toxicology (2021)
Man Zhu, Liu Yang, Xianpeng Shi, Zhengyan Gong, Runze Yu, Dongdong Zhang, Yanmin Zhang, Weina Ma
TPD7 inhibits the growth of cutaneous T cell lymphoma H9 cell through regulating IL-2R signalling pathway. Journal of cellular and molecular medicine 24 (1) (2019)
Liu Yang, Man Zhu, Yuan Kang, Tianfeng Yang, Weina Ma
Investigation of the binding characteristics between ligands and epidermal growth factor receptor by cell membrane chromatography. Journal of molecular recognition : JMR 31 (6) (2018)